Among postmenopausal women, no association between fractures and ovarian cancer risk was observed among never users of postmenopausal hormones (RR=1.21 ever vs. never fracture, 95% CI 0.55-2.65, n=8 ovarian cancer among women with fractures), ( table3) or ever users of postmenopausal hormones (RR=1.00,95% CI 0.55-1.82)